1997
The transcriptional activator Sp1, a novel autoantigen
Spain T, Sun R, Gradzka M, Lin S, Craft J, Miller G. The transcriptional activator Sp1, a novel autoantigen. Arthritis & Rheumatism 1997, 40: 1085-1095. PMID: 9182919, DOI: 10.1002/art.1780400613.Peer-Reviewed Original ResearchConceptsTranscriptional activator Sp1Novel autoantigenComplex of DNAGC-rich sequencesActivator Sp1Undifferentiated connective tissue diseaseSp1 proteinTranscription activatorConnective tissue diseaseExtractable nuclear antigensEpstein-Barr virusSp1Nuclear extractsCellular DNAMalar rashAntinuclear antibodiesClinical characteristicsProteinDNARaynaud's phenomenonTissue diseaseAutoantigenic proteinsAutoimmune seraElectrophoretic mobilityAutoantigens
1990
The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays
Kipnis R, Craft J, Hardin J. The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays. Arthritis & Rheumatism 1990, 33: 1431-1437. PMID: 2403405, DOI: 10.1002/art.1780330917.Peer-Reviewed Original ResearchConceptsCommon antibody specificitiesPrimary Raynaud's phenomenonScleroderma overlap syndromeOverlap syndromeDiffuse sclerodermaRaynaud's phenomenonRNP antibodiesCREST syndromeAntinucleolar autoantibodiesAmerican patientsRadioimmunoprecipitation assaysAutoantibodiesIndirect immunofluorescenceSclerodermaAntibody specificityNucleolar antigensPatientsSyndromeAntibodiesImmunoprecipitation assaysAssays